文献速递传染病防控与疫情报告免疫规划卫生政策与健康促进

法国医院2013至2024年甲型肝炎严重程度与死亡趋势及危险因素:全国性人群研究

Trends and risk factors associated with hepatitis A severity and mortality in French hospitals: a national population-based study, 2013 to 2024.
PubMed 文献 · Euro Surveill · 2026-01-01

该研究基于法国国家出院数据集,纳入2013至2024年因甲型肝炎住院的7923例患者,分析严重甲肝和死亡的危险因素及时间趋势。结果显示28.7%发生严重甲肝,1.30%死亡;高龄、男性、吸烟、慢性肝病危险因素和肝硬化与严重甲肝相关,肝硬化和高Charlson共病指数与死亡相关。2021至2024年严重甲肝和死亡风险较2013至2016年分别增加57%和1.96倍。

要点

  • 法国住院甲肝患者中28.7%发生严重甲肝,1.30%死亡。
  • 高龄、男性、吸烟、慢性肝病危险因素和肝硬化与严重甲肝相关。
  • 肝硬化和高Charlson共病指数与甲肝死亡相关。

核心结论

  • 自2013年以来法国医院严重甲肝频率和死亡率增加。
  • 年龄和男性与严重疾病相关,高Charlson共病指数与死亡相关。
  • 可考虑更广泛或甚至普遍的疫苗接种政策。

研究设计与样本

  • 基于法国国家出院数据集,采用国际疾病分类第10版代码B150或B159作为主要出院诊断识别甲肝病例。
  • 纳入2013至2024年因甲肝住院的7923例患者,其中男性60.6%、女性39.4%,中位年龄30岁。
  • 使用调整比值比在原始样本和倾向性匹配样本中评估严重程度和死亡的危险因素,并分析五个时期的时间趋势,以2013-2016年为参照。

主要发现

  • 7923例中28.7%(n=2277)发生严重甲肝,1.30%(n=103)死亡。
  • 严重甲肝与年龄超过30岁后每十年增加15%(p<0.001)、男性增加38%(p<0.001)、吸烟增加23%(p=0.031)、慢性肝病危险因素增加29%(p=0.041)和肝硬化增加40%(p=0.054)相关。
  • 死亡与肝硬化增加2.90倍(p=0.004)、Charlson共病指数≥3增加12.3倍(p<0.001)和年龄增加24%(p=0.005)相关,在无Charlson共病指数的模型中年龄增加达90%(p<0.001)。
  • 与2013-2016年相比,2021-2024年严重甲肝风险增加57%(p<0.001),甲肝相关死亡风险增加1.96倍(p=0.016)。

临床怎么用

  • 临床应关注高龄、男性、吸烟、慢性肝病危险因素和肝硬化等严重甲肝危险因素。
  • 对肝硬化或Charlson共病指数≥3的甲肝患者应警惕死亡风险。
  • 公共卫生层面可考虑更广泛或普遍的甲肝疫苗接种策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUNDAs hepatitis A (HA) incidence declines in Europe and HA virus infections occur later in life, severe disease frequency may increase.AIMAmong patients hospitalised for HA in France during 2013-2024, we investigated disease severity and mortality associated-risk factors and temporal trends.METHODSInternational Classification of Diseases, 10th Revision codes B150 or B159 as primary discharge diagnosis enabled identifying HA cases from the National Discharge Data Set. Risk factors for severity (hepatic and/or extrahepatic organ failure within 12 weeks post-admission) and mortality were assessed using adjusted odds ratios in original and propensity-matched samples. Trends were determined across five periods covering an HA epidemic in 2017 and the COVID-19 pandemic, with 2013-2016 as reference.RESULTSAmong 7,923 cases (60.6% male, 39.4% female; median age: 30 years), 28.7% (n = 2,277) developed severe HA, and 1.30% (n = 103) died. Severe HA was associated with older age (+ 15% per decade over 30 years, p < 0.001), male sex (+ 38%, p < 0.001), smoking (+ 23%, p = 0.031), risk factors for chronic liver disease (+ 29%, p = 0.041), and cirrhosis (+ 40%, p = 0.054). Mortality was associated with cirrhosis (2.90-fold increase, p = 0.004), Charlson Comorbidity Index (CCI) ≥ 3 (12.3-fold increase, p < 0.001), and modestly with age (+ 24%, p = 0.005), reaching + 90% (p < 0.001) in models without CCI, indicating a considerable comorbidity effect. From 2013-2016, severe HA and HA-related death risks respectively increased 57% (p < 0.001) and 1.96-fold (p = 0.016) in 2021-2024.CONCLUSIONSSevere HA frequency and mortality increased in French hospitals since 2013. Age and male sex were associated with severe disease, and high CCI with mortality. A more extensive, or even universal, vaccination policy could be considered.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Roque-Afonso AM, Mouliade C, Parlati L, et al. Trends and risk factors associated with hepatitis A severity and mortality in French hospitals: a national population-based study, 2013 to 2024. Euro Surveill. 2026. PMID: 42825337. doi:10.2807/1560-7917.ES.2026.31.39.2500858

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。